BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tefas LR, Barbălată C, Tefas C, Tomuță I. Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy. Pharmaceutics 2021;13:1120. [PMID: 34452081 DOI: 10.3390/pharmaceutics13081120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Anees M, Mehrotra N, Tiwari S, Kumar D, Kharbanda S, Singh H. Polylactic acid based biodegradable hybrid block copolymeric nanoparticle mediated co-delivery of salinomycin and doxorubicin for cancer therapy. Int J Pharm 2023;635:122779. [PMID: 36842520 DOI: 10.1016/j.ijpharm.2023.122779] [Reference Citation Analysis]
2 Tefas LR, Toma I, Sesarman A, Banciu M, Jurj A, Berindan-neagoe I, Rus L, Stiufiuc R, Tomuta I. Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer. Journal of Liposome Research 2022. [DOI: 10.1080/08982104.2022.2153139] [Reference Citation Analysis]
3 Nayak A, Warrier NM, Kumar P. Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems. Stem Cell Rev Rep 2022. [PMID: 35876959 DOI: 10.1007/s12015-022-10426-9] [Reference Citation Analysis]
4 Contreras-torres FF, Salas-treviño D, Soto-domínguez A, De Jesús García-rivas G. Carbon Nanotubes in Tumor-Targeted Chemotherapeutic Formulations: A Review of Opportunities and Challenges. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01118] [Reference Citation Analysis]
5 Chai AWY, Tan AC, Cheong SC. Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis. Sci Rep 2021;11:23933. [PMID: 34907286 DOI: 10.1038/s41598-021-03418-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]